Commentary
- PMID: 23813429
- DOI: 10.1373/clinchem.2012.200428
Commentary
Comment on
-
Poor response to thiopurine in inflammatory bowel disease: how to overcome therapeutic resistance?Clin Chem. 2013 Jul;59(7):1023-6. doi: 10.1373/clinchem.2012.195750. Clin Chem. 2013. PMID: 23813427 No abstract available.
Similar articles
-
Commentary.Clin Chem. 2013 Jul;59(7):1026. doi: 10.1373/clinchem.2012.200410. Clin Chem. 2013. PMID: 23813428 No abstract available.
-
Can azathioprine 6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: what is the most appropriate time for this?Turk J Gastroenterol. 2012;23 Suppl 2:17-20. doi: 10.4318/tjg.2012.0618. Turk J Gastroenterol. 2012. PMID: 23576085 Review. No abstract available.
-
Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.Inflamm Bowel Dis. 2016 Nov;22(11):2733-2747. doi: 10.1097/MIB.0000000000000923. Inflamm Bowel Dis. 2016. PMID: 27760078
-
How long should we treat patients with azathioprine/6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?Turk J Gastroenterol. 2012;23 Suppl 2:13-6. doi: 10.4318/tjg.2012.0617. Turk J Gastroenterol. 2012. PMID: 23576084 Review. No abstract available.
-
"Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis.J Clin Gastroenterol. 2011 Jul;45(6):479-80. doi: 10.1097/MCG.0b013e3182160cb5. J Clin Gastroenterol. 2011. PMID: 21552139 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical